Niagen Bioscience names Abhijit Kale senior director of global external research
NAGE•Niagen Bioscience appoints new research leader
Niagen Bioscience named Abhijit Kale as senior director of global external research, effective July 20, 2026.
Kale will run the Niagen Research Program, steering external academic and clinical collaborations and shaping research strategy in NAD+ biology.
He was most recently a scientific review officer at Hevolution Foundation, where he reviewed more than 600 proposals tied to a $1 billion longevity portfolio.
Earlier roles included leadership posts at Buck Institute for Research on Aging, Deciduous Therapeutics and LevitasBio.
The program supports more than 175 active or developing studies, with more than 45 peer-reviewed published clinical studies on Niagen.
Related News
Vistra unit TXU Energy lifts receivables securitization facility to $1.25 billion, extends to July 2027
VST•
Trulieve publishes investor presentation highlighting US medical cannabis scale, NYSE listing shift to DEA-registered operations
TRLV•
